Bortezomib — Dosing in CKD & Dialysis
Bortezomib (Proteasome Inhibitor): renal dosing adjustments, dialyzability (Not quantified. The label advises giving VELCADE after the dialysis procedure in patients requiring dialysis (8.6) and found no clinically significant pharmacokinetic differences by renal impairment, including patients dosed